BTG plc is engaged in development and commercialisation of life science technologies. The company licenses, develops and commercializes pharmaceuticals and has a pipeline of development programmes targeting neurological and other disorders, including varicose veins. The Company also has a substantial and growing revenue stream of milestone payments and royalties from out-licensed products.